跳至主要内容
临床试验/NCT05912686
NCT05912686尚未招募4 期

High Dose of Atorvastatin for Preventing Cerebral Vascular Wall Damage in Patients Undergoing Mechanical Thrombectomy

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2023年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
162
试验地点
1
主要终点
Cerebral vascular wall damage

研究概览

简要总结

This project investigates the impact of statins on cerebral vascular wall damage after mechanical thrombectomy. The investigators will undertake a multi-center, prospective, parallel-controlled, open-label, superiority randomized controlled study based on past research on intense lipid-lowering intervention trials. Patients undergoing post-thrombectomy will be divided into two groups: the test group and the control group. After surgery, the test group will be given a high dose of atorvastatin (80mg/day), followed by a standard dose (20mg/day). The control group will continue to receive the standard dose of atorvastatin (20mg/day). The investigators will compare the high-resolution vascular wall MRI characteristics (vascular wall enhancement, lumen stenosis rate, and so on) within 3-5 days of the operation, as well as the composite incidence of ischemic stroke, transient ischemic attack, intracranial hemorrhage 1 month postoperatively, and the modified Rankin Score at 90 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of acute ischemic stroke;
  • With anterior circulation acute stroke who meet and receive emergency endovascular treatment;
  • CTA or DSA confirms anterior circulation intracranial arterial lesions, including MT of intracranial arteries (middle cerebral artery (MCA), internal carotid artery (ICA), basilar artery and/or vertebral artery and P1 segment of posterior cerebral artery (PCA);
  • Recanalization of blood vessels after operation (mTICI ≥ 2b grade)

排除标准

  • Placing permanent stents or other implants in the target artery
  • Can not receive HR-VWI examination of 3T MRI due to claustrophobia or unstable condition
  • Contraindications to MRI and/or intravenous gadolinium

研究组 & 干预措施

high-dose arm

Active Comparator

The test group will undergo high-dose atorvastatin treatment (80mg/day) for the first 3 days after the mechanical embolectomy, transitioning to a standard dose (20mg/day) of atorvastatin thereafter.

干预措施: Atorvastatin 80mg (Drug)

standard-dose arm

Other

a standard dose (20mg/day) of atorvastatin after the mechanical embolectomy

干预措施: Atorvastatin 20mg (Drug)

结局指标

主要结局

Cerebral vascular wall damage

时间窗: within 5-7 days after MT

Incidence of T1 hyperintensity and T1 shortening within the arterial wall in HR-VWI

次要结局

  • Target vessel stenosis rate(Within 5-7 days after MT)
  • Perioperative complications(Within 30 days after MT)
  • Neurological function evaluation(Within 90 days after MT)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gao-jun Teng

Dean

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验